University Heights, OH, United States of America

Colin Combs

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Case Western Reserve University. Active years: 2001.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colin Combs: Innovator in Alzheimer's Disease Treatment

Introduction

Colin Combs is a notable inventor based in University Heights, OH (US). He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease and related conditions. His innovative work focuses on developing methods and compositions that address the inflammatory components associated with these diseases.

Latest Patents

Colin Combs holds 1 patent for his invention titled "Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases." This patent outlines methods and compositions aimed at treating Alzheimer's disease and other conditions characterized by inflammation. The invention specifically provides agents that regulate the production of proinflammatory and neurotoxic products involved in these diseases.

Career Highlights

Colin Combs is affiliated with Case Western Reserve University, where he conducts his research and development work. His career has been marked by a commitment to advancing the understanding and treatment of neurodegenerative diseases. His innovative approaches have garnered attention in the scientific community.

Collaborations

Colin has collaborated with esteemed colleagues such as Gary Landreth and Jerry Silver. These partnerships have enhanced his research efforts and contributed to the advancement of knowledge in the field of Alzheimer's disease.

Conclusion

Colin Combs is a dedicated inventor whose work is making a difference in the treatment of Alzheimer's disease. His innovative methods and compositions hold promise for improving the lives of those affected by this challenging condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…